Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Third Harmonic Bio logo — Advancing the next wave of medicine for inflammatory disease...

Third Harmonic Bio

Advancing the next wave of medicine for inflammatory diseases

Founded 2019 United States San Francisco, United States 8 employees Series B Total: $155.00M Biotechnology, Health Care +1

General Information

Company Name Third Harmonic Bio
Founded Year 2019
Location United States San Francisco, United States +2
Employees 8
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Series B
Social

Get notified when Third Harmonic Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Third Harmonic Bio

Third Harmonic Bio, founded in 2019, is a clinical-stage biopharmaceutical company with the slogan "Advancing the next wave of medicine for inflammatory diseases." The company is focused on developing a highly selective, oral KIT inhibitor for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases. Their approach revolves around targeting KIT, a cell surface receptor that plays a crucial role in regulating mast cells, the key mediators of inflammation in mast-cell mediated inflammatory diseases. By inhibiting KIT, Third Harmonic Bio aims to provide broad symptomatic relief for patients with conditions such as chronic spontaneous urticaria and severe asthma. In January 2022, the company successfully secured a $105.00M Series B investment from a consortium of prominent investors including General Atlantic, RA Capital Management, Boxer Capital, Ajax Health, Commodore Capital, Deep Track Capital, RTW Investments, and Biotechnology Value Fund. With a focus on biotechnology and healthcare industries, Third Harmonic Bio stands at the forefront of innovative solutions for inflammatory diseases.

Taxonomy: biopharmaceutical, clinical-stage, KIT inhibitor, inflammatory diseases, dermal diseases, respiratory diseases, gastrointestinal diseases, mast cells, chronic spontaneous urticaria, severe asthma, allergy, allergic diseases, immune cells, drug development, medical research

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 8
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		16 Jan 2022
Series A •••••• 2
Investor
•••• •••• 		01 Jan 2019

Third Harmonic Bio Alternatives & Competitors

Third Harmonic Bio vs
Tr1X
Tr1X United States

Engineering cures for patients with autoimmune & inflammatory diseases.

Unknown
46 employees
Biotechnology, Health Care
Third Harmonic Bio vs
Artax Biopharma Inc
Artax Biopharma Inc

Developing oral first-in-class Nck blockers for the treatment of T cell mediated autoimmune diseases

Series Unknown
14 employees
Biopharma, Biotechnology
Third Harmonic Bio vs
GRI Bio, Inc.
GRI Bio, Inc. United States

Advancing Pipeline of Natural Killer T Cell Modulators for the Treatment of Inflammatory and Fibroti...

12 employees

FAQ About Third Harmonic Bio

Advancing the next wave of medicine for inflammatory diseases
Third Harmonic Bio was founded in 2019.
Third Harmonic Bio is headquartered in San Francisco, United States.
Third Harmonic Bio operates in the following industries: Biotechnology, Health Care, Life Sciences.
Third Harmonic Bio has approximately 8 employees.
Third Harmonic Bio has completed 2 funding rounds, raising a total of $155.00M. The latest funding stage is Series B.
Top alternatives and competitors to Third Harmonic Bio include Tr1X, Artax Biopharma Inc, GRI Bio, Inc., Celularity Inc., AbolerIS Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Third Harmonic Bio and Tr1X are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Third Harmonic Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy